You have 9 free searches left this month | for more free features.

Anti-Infective Agents

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clinical Trials of Investigational or Licensed Vaccines or

Recruiting
  • Vaccines
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Alcohol Drinking, Alcohol-Related Disorders, Disease Trial in Catonsville (Minocycline, Sugar pill)

    Recruiting
    • Alcohol Drinking
    • +15 more
    • Catonsville, Maryland
      Maryland Psychiatric Research Center (MPRC) Treatment Research P
    Nov 29, 2022

    Infection Trial in Poitiers (Blood and cerebrospinal fluid pharmacocinetic samples on one of the nine antibiotics prescribed in

    Recruiting
    • Infection
    • Blood and cerebrospinal fluid pharmacocinetic samples on one of the nine antibiotics prescribed in routine use
    • Poitiers, France
      CHU of Poitiers
    Sep 13, 2021

    Communicable Diseases, Infection, Anti-Infective Agents Trial in Saint Louis (Probiotic, Placebo)

    Completed
    • Communicable Diseases
    • +4 more
    • Probiotic
    • Placebo
    • Saint Louis, Missouri
      Washington University School of Medicine
    Mar 29, 2022

    Infections, Vector Borne Diseases, Systemic Inflammatory Response Syndrome Trial in Brisbane (MMV367, P. falciparum IBSM

    Recruiting
    • Infections
    • +11 more
    • MMV367
    • P. falciparum IBSM infection
    • Brisbane, Queensland, Australia
    • +1 more
    Jul 30, 2023

    Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

    Recruiting
    • Leukemia
    • +19 more
    • CYNK-001
    • Denver, Colorado
    • +9 more
    Sep 9, 2022

    Anti Infective Agents Impact in COVID-19 Pneumonia

    Completed
    • COVID
    • Pneumonia, Viral
    • favorable outcome
    • Garches, France
      Benjamin Davido
    Jun 30, 2020

    Early Ventilation Acquired Pneumonia in Brain Injured Patients Trial in France (Anti-Infective Agents, Placebo)

    Completed
    • Early Ventilation Acquired Pneumonia in Brain Injured Patients
    • Anti-Infective Agents
    • Placebo
    • Angers, France
    • +7 more
    Feb 2, 2021

    Pancreaticoduodenectomy, Antibiotherapy Trial (Antibioprophylaxis (Piperacillin-tazobactam), 5 days Antibiotherapy

    Not yet recruiting
    • Pancreaticoduodenectomy
    • Antibiotherapy
    • Antibioprophylaxis (Piperacillin-tazobactam)
    • 5 days Antibiotherapy (Piperacillin-tazobactam)
    • (no location specified)
    Nov 3, 2023

    Compliance of Initial Empiric Antimicrobial Therapy

    Completed
    • Anti-Infective Agents
    • microbiological investigation
    • Warsaw, Poland
      Department of Anesthesiology and Intensive Therapy
    Jun 25, 2020

    Covid19 Trial in Scottsdale (Atovaquone/Azithromycin)

    Terminated
    • Covid19
    • Scottsdale, Arizona
      HonorHealth
    Feb 16, 2022

    Non Small Cell Lung Cancer, Stage I Lung Cancer, Stage Ib Lung Carcinoma Trial in Winston-Salem (Vitamin A Compound, Therapeutic

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • +5 more
    • Vitamin A Compound
    • Therapeutic Conventional Surgery
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Jan 5, 2023

    Advanced Solid Tumor Trial (SHR-A1921;)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Feb 28, 2023

    Anti-Infective Agents, Mobile Applications, Quality Improvement Trial in Worldwide (AB-assistant)

    Unknown status
    • Anti-Infective Agents
    • +3 more
    • AB-assistant
    • Calgary, Alberta, Canada
    • +3 more
    Jul 31, 2020

    Stroke, Medication Adherence Trial in Kumasi (Polycap)

    Not yet recruiting
    • Stroke
    • Medication Adherence
    • Kumasi, Ghana
      Kwame Nkrumah Institute of Science & Technology
    Jul 19, 2023

    Acute Exacerbation of Bronchiectasis Trial in Shanghai (anti-infective therapy sitafloxacin, anti-infective therapy

    Active, not recruiting
    • Acute Exacerbation of Bronchiectasis
    • anti-infective therapy sitafloxacin
    • anti-infective therapy levofloxacin
    • Shanghai, Shanghai, China
      Shanghai pulmonary hospital
    Apr 5, 2022

    Peri-Implantitis, Plaque, Dental Trial in Stockholm (Lumoral Treatment, Standard oral hygiene instructions, Scaling and root

    Not yet recruiting
    • Peri-Implantitis
    • Plaque, Dental
    • Lumoral Treatment
    • +3 more
    • Stockholm, Sweden
      Södertandläkarna AB
    Sep 5, 2023

    Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))

    Not yet recruiting
    • Uncomplicated Plasmodium Falciparum Malaria
    • (no location specified)
    Feb 17, 2023

    Respiferon Project

    Recruiting
    • Respiratory Viral Infection
    • Evaluate the performance of IFN I/III
    • Lyon, Rhone, France
      Infective Agents Institute, Croix rousse Hospital
    Aug 24, 2023

    Anti-infective Drugs Used in Pediatric Units.

    Active, not recruiting
    • Population Modeling of Anti-infective Drugs
    • Patients requiring cefotaxime treatment
    • +4 more
    • Poznań, Długa 1/2, Poland
    • +3 more
    Jun 21, 2022

    Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and

    Not yet recruiting
    • Disability or Chronic Disease Leading to Disablement
    • +2 more
    • Surgical flap and anti-bacterial agents
    • Garches, France
      Department of Physical Medicine and Rehabilitation, Raymond Poin
    Feb 1, 2023

    Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

    Not yet recruiting
    • Relapsed/Refractory Non-Hodgkin Lymphoma
    • Duarte, California
    • +1 more
    Oct 13, 2023

    Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)

    Recruiting
    • Solid Tumor
    • Chuo-ku, Tokyo, Japan
      National Cancer Center Hospital
    Jun 14, 2023

    NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • (no location specified)
    Sep 6, 2023

    Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

    Not yet recruiting
    • Cancer
    • +6 more
    • (no location specified)
    Oct 16, 2023